IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report

被引:0
|
作者
Huang, Meichun [1 ]
Liu, Jun [1 ]
Li, Xiuxiu [1 ]
机构
[1] Tongde Hosp Zhejiang Prov, Renal Dept, 234 Gucui Rd, Hangzhou 310012, Peoples R China
来源
OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期
关键词
IgG4-related disease; IgG4-related kidney disease; membranous nephropathy; phospholipase A2 receptor; Tripterygium wilfordii; TRIPTERYGIUM-WILFORDII; TRIPTOLIDE; MECHANISM; CELLS;
D O I
10.1515/biol-2022-0921
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
IgG4-related tubulointerstitial nephritis (IgG4-related TIN) is the prevalent clinical manifestation of IgG4-related diseases (IgG4-RD). However, there are limited cases of IgG4-RD occurring with membranous nephropathy (MN) in the absence of phospholipase A2 receptor (PLA2R). There have been no indications of treatment using Tripterygium wilfordii. This study reported a rare case of IgG4-RD with PLA2R-associated MN without any of the distinct IgG4-related TIN. The patient was treated effectively with T. wilfordii. A 71-year-old patient was admitted to the medical facility after presenting with a 1 month history of edema and 8 months of albuminuria. The renal biopsy tissue examination confirmed the presence of MN (phase II) in the absence of pathological manifestations of IgG4-related TIN. Immunohistochemistry identified PLA2R++ (granular capillaries). The serum PLA2R antibody titer was 1:180 (1:20). The patient met the diagnosis with IgG4-RD. Over 8 years of follow-up, the patient was effectively treated with low-dose hormones and T. wilfordii, without any adverse effects. This MN is considered a unique form of IgG4-RD, regardless of whether PLA2R antibodies are present or not. Research suggests that T. wilfordii could be a promising option for elderly people with IgG4-related MN, as it has been found to have fewer adverse effects.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2090 - I2091
  • [22] Concurrent glomerular PCDH7 deposits in PLA2R-associated membranous nephropathy
    Fu, Nana
    Yuan, Shuang
    Yang, Guang
    Li, Hang
    Wang, Tao
    CEN CASE REPORTS, 2024, 13 (04) : 297 - 301
  • [23] The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy
    Bai, Yu
    Liu, Jing
    Duan, Yajuan
    Liu, Wenhu
    Diao, Zongli
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (03): : 404 - 406
  • [24] Combined Serologic and Genetic Risk Score and Prognostication of PLA2R-Associated Membranous Nephropathy
    Hu, Xiaofan
    Xu, Jing
    Wang, Wei
    Liu, Lili
    Jing, Yuanmeng
    Gao, Chenni
    Yu, Xialian
    Li, Yi
    Lin, Li
    Tong, Jun
    Weng, Qinjie
    Pan, Xiaoxia
    Zhang, Wen
    Ren, Hong
    Li, Guisen
    Kiryluk, Krzysztof
    Chen, Nan
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (05): : 573 - 582
  • [25] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [26] IgG4-Related Membranous Nephropathy After COVID-19 Vaccination: A Case Report
    Mizuno, Tomohito
    Endo, Yoko
    Suzuki, Atsushi
    Suzuki, Masashi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [27] IgG4-Related Tubulointerstitial Nephritis With Membranous Nephropathy
    Fervenza, Fernando C.
    Downer, Gregory
    Beck, Laurence H., Jr.
    Sethi, Sanjeev
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (02) : 320 - 324
  • [28] Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
    Guo, Yaling
    Wu, Xueping
    Liu, Lei
    Zhang, Haifeng
    Yang, Lijuan
    Chen, Weidong
    RENAL FAILURE, 2020, 42 (01) : 122 - 130
  • [29] Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?
    Salant, David J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (08): : 1122 - 1124
  • [30] Rituximab in the treatment of PLA2R-associated membranous nephropathy: insights from a hospital centre experience
    Henriques, Andreia Dos Santos
    Venda, Joao
    Ferreira, Emanuel
    Oliveira, Nuno
    Alves, Rui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I663 - I663